| 2026-05-14 | Mr. Michael A. BieberCEO, Director & President | -56,68k | 4,07M | Derivative Exercise and Sale | 16,27 - 93,74 | 212,86k | - |
| 2026-05-13 | Mr. Michael A. BieberCEO, Director & President | -9,99k | 763,11k | Derivative Exercise and Sale | 16,27 - 92,65 | 212,86k | - |
| 2026-03-25 | Mr. Micah H. ChenExec. VP & General Counsel | -1,66k | 137,45k | Sale to Issuer | 82,80 | 41,07k | -3,88% |
| 2026-03-25 | Mr. Michael A. BieberCEO, Director & President | -6,44k | 533,56k | Sale to Issuer | 82,80 | 212,86k | -2,94% |
| 2026-03-25 | Mr. Creighton K. EarlyExec. VP & CFO | -2,14k | 177,36k | Sale to Issuer | 82,80 | 68,56k | -3,03% |
| 2026-03-20 | Mr. Micah H. ChenExec. VP & General Counsel | -615,00 | 46,44k | Sale to Issuer | 75,52 | 47,93k | -1,27% |
| 2026-03-20 | Mr. Michael A. BieberCEO, Director & President | -2,39k | 180,27k | Sale to Issuer | 75,52 | 203,55k | -1,16% |
| 2026-03-20 | Mr. Creighton K. EarlyExec. VP & CFO | -794,00 | 59,96k | Sale to Issuer | 75,52 | 66,92k | -1,17% |
| 2026-03-17 | Mr. Michael A. BieberCEO, Director & President | -2,63k | 205,51k | Sale to Issuer | 78,29 | 200,11k | -1,29% |
| 2026-03-17 | Mr. Micah H. ChenExec. VP & General Counsel | -676,00 | 52,92k | Sale to Issuer | 78,29 | 38,17k | -1,74% |
| 2026-03-17 | Mr. Creighton K. EarlyExec. VP & CFO | -873,00 | 68,35k | Sale to Issuer | 78,29 | 66,32k | -1,30% |
| 2026-03-16 | Mr. Micah H. ChenExec. VP & General Counsel | -1,83k | 143,54k | Sale to Issuer | 78,61 | 37,30k | -4,67% |
| 2026-03-16 | Mr. Michael A. BieberCEO, Director & President | -7,09k | 557,34k | Sale to Issuer | 78,61 | 196,31k | -3,49% |
| 2026-03-16 | Mr. Creighton K. EarlyExec. VP & CFO | -2,36k | 185,21k | Sale to Issuer | 78,61 | 65,65k | -3,46% |
| 2026-03-11 | Mr. Micah H. ChenExec. VP & General Counsel | -1,74k | 145,96k | Sale to Issuer | 83,98 | 34,97k | -4,73% |
| 2026-03-11 | Mr. Michael A. BieberCEO, Director & President | -7,70k | 646,39k | Sale to Issuer | 83,98 | 186,08k | -3,97% |
| 2026-03-11 | Mr. Creighton K. EarlyExec. VP & CFO | -2,24k | 188,45k | Sale to Issuer | 83,98 | 63,85k | -3,40% |
| 2026-03-09 | Mr. Micah H. ChenExec. VP & General Counsel | -410,00 | 34,02k | Sale to Issuer | 82,98 | 44,67k | -0,91% |
| 2026-03-09 | Mr. Michael A. BieberCEO, Director & President | -1,81k | 150,53k | Sale to Issuer | 82,98 | 223,88k | -0,80% |
| 2026-03-09 | Mr. Creighton K. EarlyExec. VP & CFO | -4,31k | 357,39k | Sale to Issuer | 82,98 | 75,18k | -5,42% |
| 2026-03-06 | Dr. Steven A. CohenLead Independent Director | -6,00k | 490,92k | Verkauf | 81,82 | 20,85k | -22,35% |
| 2025-09-18 | Mr. Micah H. ChenExec. VP & General Counsel | -10,00k | 732,10k | Derivative Exercise and Sale | 32,79 - 106,00 | 33,00k | - |
| 2025-09-18 | Vice Admiral Dennis V. McGinnIndependent Director | -7,30k | 775,92k | Verkauf | 106,32 | 11,33k | -39,18% |
| 2025-08-25 | Dr. Thomas D. BrisbinChairman | -5,18k | 527,94k | Derivative Exercise and Sale | 16,27 - 118,15 | 70,70k | - |
| 2025-08-22 | Dr. Thomas D. BrisbinChairman | -117,60k | 12,78M | Verkauf | 104,58 - 110,84 | 70,70k | -62,45% |
| 2025-08-21 | Dr. Thomas D. BrisbinChairman | -125,00k | 13,05M | Verkauf | 101,87 - 106,34 | 188,29k | -39,90% |
| 2025-08-20 | Dr. Thomas D. BrisbinChairman | -7,41k | 771,53k | Verkauf | 104,19 | 313,29k | -2,31% |
| 2025-08-18 | Dr. Thomas D. BrisbinChairman | -5,08k | 488,24k | Derivative Exercise and Sale | 16,27 - 113,01 | 320,70k | - |
| 2025-08-18 | Dr. Thomas D. BrisbinChairman | -125,00k | 13,70M | Verkauf | 108,63 - 111,21 | 320,70k | -28,05% |
| 2025-08-18 | Mr. Creighton K. EarlyExec. VP & CFO | -1,47k | 161,01k | Sale to Issuer | 109,53 | 66,26k | -2,17% |
| 2025-08-18 | Mr. Michael A. BieberCEO, Director & President | -6,79k | 743,49k | Sale to Issuer | 109,53 | 176,63k | -3,70% |
| 2025-08-18 | Mr. Micah H. ChenExec. VP & General Counsel | -1,20k | 131,11k | Sale to Issuer | 109,53 | 33,00k | -3,50% |
| 2025-08-15 | Ms. Cynthia A. DownesIndependent Director | -2,76k | 302,36k | Verkauf | 109,43 | 8,91k | -23,67% |
| 2025-08-14 | Ms. Wanda K. RederIndependent Director | -850,00 | 101,54k | Verkauf | 119,46 | 10,68k | -7,37% |
| 2025-08-13 | Mr. Creighton K. EarlyExec. VP & CFO | -7,76k | 834,32k | Derivative Exercise and Sale | 9,08 - 116,54 | 64,65k | - |
| 2025-08-12 | Dr. Steven A. CohenLead Independent Director | -2,50k | 290,85k | Verkauf | 116,34 | 26,85k | -8,52% |